跳至主要内容
临床试验/NCT04765839
NCT04765839已完成不适用

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With Minority Populations

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2021年2月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
74
试验地点
1
主要终点
COVID-19 attitudes

研究概览

简要总结

A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At baseline, 2 weeks and 4 weeks, the study team will survey participants to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

详细描述

A cluster randomized trial with 80 participants from the social networks of 8 CLs will be conducted prior to widespread vaccine availability to the general public. Four CLs and social networks (cluster of 10 per network) will be randomly assigned to receive the intervention immediately or after a delay of 2 weeks. Intervention participants will be invited to a closed social media group on the platform of their choice. CLs, selected for trustworthiness within vulnerable populations, will disseminate community-informed COVID-19 vaccine messages to members of their social networks and engage in bidirectional communication with CEnR partners to refine messages. At baseline, 2 weeks and 4 weeks, participants will be surveyed to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

盲法说明

Randomization outcomes will not be disclosed to participants.

入排标准

年龄范围
18 Years 至 101 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Self-identification within a CLs social network
  • •Age 18 or greater
  • •Functional internet access.

排除标准

  • •Does not self-identify within a CLs social network
  • •Is under the age of 18
  • •Does not have functional internet access.

研究组 & 干预措施

Intervention Arm - Receives COVID-19 Vaccine messages

Experimental

Group to receive COVID-19 Vaccine messages during the first two weeks of the study.

干预措施: Educational, culturally appropriate COVID-19 messages (Other)

Delayed Intervention Arm

Experimental

Group to receive COVID-19 Vaccine messages during the last two weeks of the study.

干预措施: Educational, culturally appropriate COVID-19 messages (Other)

结局指标

主要结局

COVID-19 attitudes

时间窗: 4 weeks

Related to perceived susceptibility and preventive measures will be assessed through 3 survey instruments, based on 7-point Likert scale.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mark L Wieland

Chair, Community Internal Medicine

Mayo Clinic

研究点 (1)

Loading locations...

相似试验